Cartesian Therapeutics (RNAC)
Nasdaq • RNAC • US8162123025
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 15.4% of free float sold short, 12.1 days to cover, cost to borrow 1.14%. Sign up for live short interest data.
Market Cap
210m USD | # 7373 in US
Volume
132.16k shares | 1.03m USD
Shares Outstanding
30.5m
Free Float Shares
38.48% | 11.74m
